Literature DB >> 29758928

MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.

Wei Ding1,2,1, Hongbo Tan3,1, Xuemei Li1, Yue Zhang1, Fang Fang2, Yuanyuan Tian1, Jin Li1, Xinghua Pan4.   

Abstract

BACKGROUNDS: MicroRNAs (miRNAs) are some RNA molecules that negatively regulate gene expression by binding to the 3'-untranslated region (3'-UTR) of target mRNA molecules. The aim of the study is to investigate the clinical role and functional effects of microRNA-493 (miR-493) in human hepatocellular carcinoma (HCC).
METHODS: Expression of miR-493 in 58 cases of HCC tissues and adjacent normal tissues was determined by using quantitative real-time PCR (qRT-PCR) analyses. In vitro, cell proliferation and invasion capacity was evaluated by CCK8 assay and trans-well invasion assay. Luciferase reporter assay, western blot and qRT-PCR were used to detect the association between miR-493 expression and zinc finger protein X-linked (ZFX) in HCC.
RESULTS: Expression of miR-493 was significantly downregulated in HCC tissues compared to adjacent normal tissues. Lower miR-493 expression associated with tumor size, vascular invasion and poor overall survival (OS) and disease free survival (DFS) time of HCC patients. In vitro, transfection of miR-493 mimic in HCC cells inhibited cell proliferation and invasion abilities. However, transfection of miR-493 inhibitor in HCC cells had promoting effects. Luciferase reporter assay, qRT-PCR and western blot analysis demonstrated that miR-493 targeting 3'-untranslated region (3'-UTR) of ZFX and overexpression of miR-493 inhibited its expression. Moreover, enforced ZFX expression rescued the effects of miR-493 mimic on cell proliferation and invasion.
CONCLUSION: MiR-493 functioned as tumor suppressor in HCC cells by regulating ZFX expression. Thus, miR-493 may provide potential value for HCC treatment.

Entities:  

Keywords:  MicroRNAs; ZFX; cell invasion; cell proliferation; miR-493

Mesh:

Substances:

Year:  2018        PMID: 29758928     DOI: 10.3233/CBM-171036

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  5 in total

Review 1.  The role of PI3K/AKT signaling pathway in gallbladder carcinoma.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.

Authors:  Jian Jin; Banrida Wahlang; Hongxue Shi; Josiah E Hardesty; K Cameron Falkner; Kimberly Z Head; Sudhir Srivastava; Michael L Merchant; Shesh N Rai; Matthew C Cave; Russell A Prough
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

3.  CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.

Authors:  Chunyong Han; Xuebiao Li; Qian Fan; Guangshu Liu; Jian Yin
Journal:  Aging (Albany NY)       Date:  2019-07-16       Impact factor: 5.682

4.  Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.

Authors:  Jie Jiang; Bin Liu; Ruilin Liu; Wenzhuo Yang
Journal:  Cancer Manag Res       Date:  2021-03-16       Impact factor: 3.989

5.  miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development.

Authors:  Wei Bian; Yishuai Li; Haiyong Zhu; Shaolin Gao; Ren Niu; Chuan Wang; Hao Zhang; Xuebo Qin; Shujun Li
Journal:  Thorac Cancer       Date:  2021-04-01       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.